Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program - Reply

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{c0b3d532e3c34f8e903f7a58ef223625,

title = "Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program - Reply",

author = "James Heyward and Joshua Sharfstein and Alexander, {G. Caleb}",

year = "2020",

month = jun,

doi = "10.1001/jamainternmed.2020.1112",

language = "English (US)",

volume = "180",

pages = "916",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program - Reply

AU - Heyward, James

AU - Sharfstein, Joshua

AU - Alexander, G. Caleb

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85084301360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084301360&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2020.1112

DO - 10.1001/jamainternmed.2020.1112

M3 - Letter

C2 - 32364567

AN - SCOPUS:85084301360

VL - 180

SP - 916

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -